Search
Cognitive Impairment (CI)
go.drugbank.com/conditions/DBCOND0138824Drugs: PiracetamSynonyms: Disturbance in cognitionLevosimendan
go.drugbank.com/drugs/DB00922ApprovedInvestigationalWithdrawnLevosimendan is under investigation in clinical trial NCT00527059 (Renal Effects of Levosimendan in Patients Admitted With Acute Decompensated Heart Failure). … Levosimendan increases calcium sensitivity to myocytes by binding to troponin C in a calcium dependent manner. This increases contractility without raising calcium levels.
Categories: Compounds used in a research, industrial, or household setting, Heterocyclic Compounds, 1-RingProducts: SİMELEV 12,5 MG/5 ML IV İNFÜZYONLUK ÇÖZELTİ HAZIRLAMAK İÇİN KONSANTRE, 1 ADET, Levosimendan Win Medica 2,5 mg/ml Konzentrat zur Herstellung einer InfusionslösungRelapsed Acute Myelogenous Leukemia (AML)
go.drugbank.com/conditions/DBCOND0069493Synonyms: Acute Myelogenous Leukemia in RelapserRNA methyltransferase 2, mitochondrial
go.drugbank.com/bio_entities/BE0020789TargetHumansS-adenosyl-L-methionine-dependent 2'-O-ribose methyltransferase that catalyzes the formation of 2'-O-methyluridine at position 1369 (Um1369) in the 16S mitochondrial large subunit ribosomal RNA (mtLSU … rRNA), a universally conserved modification in the peptidyl transferase domain of the mtLSU rRNA (PubMed:25009282, PubMed:25074936, PubMed:35177605).
Synonyms: 16S rRNA [Um1369] 2'-O-methyltransferase, 16S rRNA (uridine(1369)-2'-O)-methyltransferaseFunction: rRNA (uridine-2'-O-ribose)-methyltransferase activitySucralose
go.drugbank.com/drugs/DB15049InvestigationalSucralose is an artificial sweetener used as a sugar substitute.
Categories: Compounds used in a research, industrial, or household settingProducts: DE-LİGHT 6.05 MG TABLET, 100 ADET, DE-LİGHT 6.05 MG TABLET, 300 ADETSleeping Disorders
go.drugbank.com/conditions/DBCOND0148601Synonyms: Disturbance in sleep behavior, NOS, Disturbance in sleep behavior (finding)Povidone-iodine
go.drugbank.com/drugs/DB06812ApprovedInvestigationalDuring in vitro testing to demonstrate anti-bacterial activity it was found that the complex was less toxic in mice than tincture of iodine. … This unique complex was discovered in 1955 at the Industrial Toxicology Laboratories in Philadelphia by H. A. Shelanski and M. V. Shelanski.
Synonyms: PVP-IMixtures: BRAUNODERM (IN 250ML AND 1000ML PLASTIC), Physician EZ Use Joint Tunnel and Trigger Kit IIMyeloproliferative Disorders
go.drugbank.com/conditions/DBCOND0029888Drugs: ImatinibSynonyms: Myeloproliferative disease, no ICD-O subtype, Chronic myeloproliferative disease, no ICD-O subtypeEtoricoxib
go.drugbank.com/drugs/DB01628ApprovedInvestigationalWithdrawnIt is approved in more than 60 countries worldwide but not in the US. … Etoricoxib is a new COX-2 selective inhibitor.
Categories: COX-2 Inhibitors, Cytochrome P-450 SubstratesSynonyms: 5-chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine, 5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinylAzilsartan medoxomil
go.drugbank.com/drugs/DB08822ApprovedInvestigationalIt is a selective AT1 subtype angiotensin II receptor antagonist. Azilsartan medoxomil is a relatively recently-developed antihypertensive drug that was first approved by the FDA in February 2011. … [A7354] Many guidelines recommend the use of ARBs as first-line therapy when initiating antihypertensive therapy and indicate that the clinical efficacy of ARBs is comparable to angiotensin-converting
Mixtures: EDARBI CLD®, EDARBI CLD® 40MG/12.5MGCategories: Angiotensin II Type 1 Receptor Blockers, Angiotensin II receptor antagonists